Clinical Trials

106 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04433156 2026-04-09

VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma

26 enrolled

Lymphoid

Lymphoma, B-Cell, Marginal Zone

NCT04660097 2026-04-08

Anlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer

34 enrolled

Small Cell Lung Carcinoma

NCT05394285 2026-04-06

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer

60 enrolled

Breast Neoplasms

NCT05348668 2026-01-07

Hybrid Dose-fraction Radiotherapy for Metastatic Non-small Cell Lung Cancer

78 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04553939 2026-01-02

Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer

50 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04214626 2025-11-19

R-CHOP Combined With Lenalidomide in the First-line Treatment for Patients With Diffuse Large B Cell Lymphoma

60 enrolled

Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT06333769 2025-08-15

Modified SCRT Followed by Tislelizumab Plus CAPOX for Locally Advanced Rectal Cancer

38 enrolled

Mid-low Rectal Cancer

NCT03755141 2025-07-22

Efficacy and Safety of Trastuzumab Biosimilar (Herzuma®) Plus Treatment of Physician's Choice (TPC) in Patients With HER-2 Positive Metastatic Breast Cancer

109 enrolled 7 charts

Breast Neoplasms

NCT05304546 2025-07-22

MK3475-C01

1 enrolled

Dermatologic

Melanoma, Neoplasms

NCT02078700 2025-06-25

Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study.

GastrointestinalOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT01673906 2025-06-24

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

142 enrolled

EndocrineNET

Hypersensitivity, Neuroendocrine Tumors

NCT05223088 2025-03-18

Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric Cancer

Immunotherapy

NCT05355168 2024-12-31

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

35 enrolled

Esophageal Squamous Cell Carcinoma, Drug-Related Side Effects and Adverse Reactions

NCT04664972 2024-09-20

Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC

212 enrolled

Triple Negative Breast Neoplasms

NCT03346096 2024-07-09

TEAM

50 enrolled

Lymphoid

Lymphoma

NCT03493646 2024-05-28

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT02697630 2023-12-08

PEMDAC

29 enrolled

Dermatologic

Uveal Melanoma

NCT04222790 2023-12-04

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

159 enrolled

Breast Neoplasms

NCT03950830 2023-10-04

DISGCT

12 enrolled

Neoplasms, Germ Cell and Embryonal

NCT04055792 2023-06-28

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

42 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT02408770 2023-05-06

BC-APPS1

24 enrolled

Breast Neoplasms

NCT02511223 2023-04-19

10

24 enrolled

Pancreatic Neoplasms

NCT02707159 2023-03-08

PACT-ACT-v6

70 enrolled

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT02479997 2023-02-22

Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast Cancer Patients

130 enrolled

Breast Neoplasms

NCT03058757 2023-01-31

The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation

71 enrolled

Urinary Bladder Neoplasms

NCT03735966 2022-12-01

Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.

75 enrolled

HER2 Positive Breast Cancer

NCT01003964 2022-04-12

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

289 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05315128 2022-04-07

Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

60 enrolled

Dermatologic

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Keratoacanthoma

NCT01156545 2022-04-06

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

68 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03296553 2022-01-27

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

40 enrolled 6 charts

Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Immune Reconstitution Inflammatory Syndrome

NCT04065789 2022-01-27

KyDaR

41 enrolled

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00640081 2021-09-22

Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer

169 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT02845908 2021-04-23

POF Versus FOLFOX Versus FOLFOX Plus ip Paclitaxel in AGC

90 enrolled

Stomach Neoplasms

NCT04243954 2021-03-05

Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration

95 enrolled

Cancer Pain, Agnosia

NCT02860819 2021-03-03

Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer

15 enrolled

Testicular Neoplasms

NCT04184232 2021-01-22

Treatment of Recurrent Bladder Cancer With Dendritic Cells

17 enrolled

Urinary Bladder Neoplasms

NCT03038516 2020-09-11

Palliative-D

244 enrolled

Vitamin D Deficiency

NCT02414685 2020-08-07

TIP

19 enrolled

Neoplasms, Germ Cell and Embryonal

NCT03820908 2020-08-07

Bisantrene for Relapsed /Refractory AML

Other hematologic neoplasm

10 enrolled

Leukemia, Myeloid, Acute

NCT04399577 2020-05-27

Complement Component 3c and Tumor Necrosis Factor-α in Patients With Human Papillomavirus-Induced Cutaneous Warts

39 enrolled

Warts

NCT02628860 2020-04-28

FCM

Classical hematologyGastrointestinal

Anemia, Pancreatic Neoplasms

NCT02084732 2019-11-13

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

35 enrolled

Head & Neck

Thyroid Neoplasms

NCT01774760 2019-10-04

Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck Cancer

10 enrolled 5 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03403777 2019-03-05

Avelumab in Refractory Testicular Germ Cell Cancer.

8 enrolled

Gonadal Disorders, Neoplasms, Neoplasms, Germ Cell and Embryonal, Testicular Diseases, Testicular Neoplasms

NCT01043172 2018-01-03

A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection

72 enrolled

Cholangiocarcinoma

NCT03304756 2017-10-25

CAPneo

41 enrolled

Triple Negative Breast Cancer Patients

NCT00452244 2017-08-25

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

110 enrolled

Lung Neoplasms

NCT01441297 2017-08-25

BIBF 1120 as Second Line Treatment for Small Cell Lung Cancer

24 enrolled